Human studies evaluating associations between DAGLA (and possibly also DAGLB) variants and obesity may provide some additional insight into whether modulating 2-AG synthesis impacts obesity-related outcomes. Here, DAGLB is linked to obesity due to melanocortin 4 receptor deficiency.